Surgery for Obesity and Related Diseases
Volume 5, Issue 4 , Pages 450-454, July 2009

Pilot study evaluating technical feasibility and early outcomes of second-generation endosurgical platform for treatment of weight regain after gastric bypass surgery

  • Marvin Ryou, M.D.

      Affiliations

    • Division of Gastroenterology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts
    • ,
  • Daniel K. Mullady, M.D.

      Affiliations

    • Division of Gastroenterology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts
    • ,
  • David B. Lautz, M.D.

      Affiliations

    • Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts
    • ,
  • Christopher C. Thompson, M.D., M.Sc., F.A.C.G., F.A.S.G.E.

      Affiliations

    • Division of Gastroenterology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts

Received 12 June 2008; received in revised form 16 March 2009; accepted 17 March 2009. published online 09 April 2009.

Abstract 

Background

For some gastric bypass patients, dilation of the gastrojejunal anastomosis (GJA) and/or gastric pouch is believed to contribute to weight regain. The present study had 2 objectives: (1) to assess the technical feasibility and safety of a novel endoscopic procedure called “revision obesity surgery endoscopic” (ROSE) using a second-generation, prototype endoscopic operating system that creates tissue plications to reduce the diameter of the GJA and the size of the gastric pouch; and (2) to assess the early outcomes regarding weight loss at a university hospital in the United States.

Methods

This was a prospective study of 5 patients who had regained a mean of 14.7 kg after gastric bypass with a dilated pouch and GJA on screening endoscopy. The gastric pouch and the GJA were measured before and after the procedure. The patients were followed up for a minimum of 3 months after the procedure. Weight changes were recorded.

Results

Technical success was achieved in all 5 patients (100%). The mean weight loss in the successful cases was 7.8 kg at 3 months. No major complications developed.

Conclusion

The results of our study have shown that the ROSE procedure using this second-generation prototype endoscopic operating system is technically feasible and appears safe. Our preliminary results suggest that the ROSE procedure is effective in reducing the size of both the GJA and the gastric pouch and could therefore be an alternative therapy for weight regain in postgastric bypass patients.

Keywords: NOTES, Natural orifice surgery, Revision obesity surgery endoscopic, ROSE, Revision obesity surgery, Operating platform, Gastric bypass revision, Obesity, Endoscopic obesity

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Reprints not available from the authors.

PII: S1550-7289(09)00357-8

doi:10.1016/j.soard.2009.03.217

Surgery for Obesity and Related Diseases
Volume 5, Issue 4 , Pages 450-454, July 2009

Article Tools

* Image Usage & Resolution